-
House Chair Escalates Feud With Baker Admin Over RMV Documents
A lawmaker leading the Transportation Committee's investigation into the Registry of Motor Vehicles deepened his dispute with the Baker administration Tuesday. -
Medical Expert Applauds Baker And Healey's Tough Stance On Vaping
Dr. John Winickoff, the former chair of the American Academy of Pediatrics Tobacco Consortium and a pediatrician at Mass General, supports Baker’s vape ban, and said the science backs him up. -
Revenue Debate Lingers Over Baker's $18B Transportation Bill
Gov. Charlie Baker's $18 billion transportation bond bill is, in the words of a committee chair, "more than a typical" version of a borrowing bill. -
Baker Lays Out Opposition To Purdue Settlement For Court
Gov. Charlie Baker went on record in federal bankruptcy court on Tuesday opposing a national injunction that would block lawsuits like the one filed by Massachusetts against Oxycontin manufacturer Purdue Pharma and the Sackler family. -
Shirley Leung: 'Better To Be Safe Than Sorry' On Vaping
The governor has faced criticism for imposing a four month ban on vaping devices, but the Boston Globe business columnist said she thinks Baker made the right call. -
Baker Stands By Vape Ban Decision, Says It Wasn't Easy
Gov. Charlie Baker has been both applauded and threatened with legal action in the days since rolling out the first-in-the-nation ban on all vaping products. -
Cannabis Control Commission Chair Concerned Vaping Ban Could Impact Medical Patients
Steve Hoffman said that while he's not critical of a four-month ban on vaping products, he is concerned it will have negative consequences. -
Ask The Governor: 09/19/19
On Sept. 19, 2019 Gov. Charlie Baker joined Boston Public Radio for another edition of "Ask the Governor." -
Baker Says His Office Was Unaware Of Problems At RMV
“If I had known about it I would have fixed it, and once I did know about it I did,” Baker said. -
Gov. Baker Stands With AG Healey In Rejecting Purdue Pharma Settlement
Healey sued Purdue Pharma and its executives after her office found that Purdue sales reps made 150,000 visits to medical offices from 2008 to 2018 and sold 70 million doses of opioids.